Αρχική World News News digest – sponge on a string, junk food watershed, prostate cancer...

News digest – sponge on a string, junk food watershed, prostate cancer AI and mobile phones?

With news about the coronavirus pandemic developing daily, we’re pulling together the latest government and NHS health updates from across the UK in a separate blog post, which we’re updating regularly.

Sponge on a string could transform oesophageal cancer diagnosis

A new ‘sponge on a string’ test could identify 10 times more people with Barrett’s oesophagus – a precursor to oesophageal cancer – than current testing methods, according to our scientists. Find out more in our blog post and the Express & Star.

New obesity strategy launched in ‘landmark day for nation’s health’

The UK Government has launched a new strategy to tackle obesity in the UK. New measures include restrictions on junk food marketing on TV and online, along with bans on multi-buy offers and certain instore promotions on high fat food products. There are also new rules for displaying calories on restaurant menus. The new strategy arrives amid growing evidence of a link between obesity and an increased risk from COVID-19. Head over to our blog or BBC News for the story.

AI could help detect prostate cancer

Using artificial intelligence (AI) software to scan biopsy samples could help flag prostate cancers that may otherwise have gone undetected. Medical experts have said that while the algorithm could be useful in overcoming pathologists’ own biases, the findings don’t necessarily prove that the AI’s diagnosis can be considered superior to humans, and that more research with larger samples sizes is needed. More on this at iNews.

Scientists identify new drug target for aggressive breast cancer

iNews reports scientists have uncovered a way to slow breast cancer stem cell growth in the lab. The team were particularly interested in stem cells that are resistant to hormone therapy, which can often be present when breast cancers come back after treatment, and believe the target they’ve identified could open the door to new treatments. Dr Bruno Simões from the University of Manchester said: “There’s a very long way to go before we can say if this approach will help these women, but we are excited by our findings.”

‘Higher end of normal’ blood platelet count could indicate cancer

Blood platelet counts at the high end of normal could be linked to an increased risk of cancer in men aged 60 or over, according to new research by the University of Exeter. High platelet count (otherwise known as thrombocytosis) has previously been linked to cancer, but this study looked at the records of 300,000 patients with platelet counts that were at the high end of the normal range. But despite the size of the study, more research is needed to confirm the link and talk of a diagnostic tool may be premature. Read more at MedicalXpress.

Scientists develop new method to selectively kill off cancer cells

New Atlas reports on a new development where scientist use “synthetic lethality” – when a build-up of DNA errors that normally wouldn’t harm a cell suddenly become deadly – to selectively kill off cancer without harming healthy cells in the lab. It’s still early days, but researchers hope the study could open the door to new drug targets.

And finally…

Mobile phones and cancer have hit the headlines again, as new research claims to have found a link between levels of blue light – used in billboard ads as well as many tablet and mobile devices – and an increased risk of bowel cancer.

But despite some bold headlines, the study only compared levels of blue light in different neighbourhoods using satellite images, rather than looking at individual people’s exposure. The study found that residents in areas with the highest exposure to outdoor blue light – the same light used in many tablet and mobile devices – had a higher risk compared to those with the lowest exposure.

Experts have said that while the findings are ‘interesting’, the research wasn’t able to take in consideration several factors linked to bowel cancer, and it’s impossible to tell from this study whether artificial light causes the disease. More on this at Daily Mail and Sky News.

Scarlett Sangster is a writer for PA Media Group

More on this topic



Συμπληρώστε το email σας για να λαμβάνετε τις σημαντικότερες ειδήσεις από το ogkologos.com

Βρείτε μας

2,449ΥποστηρικτέςΚάντε Like

Διαβαστε Επίσης

Καρκίνος και Κορωνοϊός (COVID-19) ΜΕΡΟΣ Α

Εάν είστε καρκινοπαθής, το ανοσοποιητικό σας σύστημα μπορεί να μην είναι τόσο ισχυρό όσο κανονικά, έτσι μπορεί να ανησυχείτε για τους κινδύνους που σχετίζονται...


Η Παγκόσμια Ημέρα Κατά του Καρκίνου καθιερώθηκε με πρωτοβουλία της Διεθνούς Ένωσης κατά του Καρκίνου (UICC), που εκπροσωπεί 800 οργανώσεις σε 155 χώρες του...


ΕΞΕΛΙΞΕΙΣ ΣΤΗ ΘΕΡΑΠΕΙΑ ΤΟΥ ΜΗ-ΜΙΚΡΟΚΥΤΤΑΡΙΚΟΥ ΚΑΡΚΙΝΟΥ ΤΟΥ ΠΝΕΥΜΟΝΑ (ΜΜΚΠ) Γράφει ο Δρ Παπαδούρης Σάββας, Παθόλογος-Ογκολόγος   Ο ΜΜΚΠ βρίσκεται αναλογικά στο 80% και πλέον του συνολικού...

Διατρέχουν όντως οι καρκινοπαθείς μεγαλύτερο κίνδυνο λόγω κοροναϊού;

Σε πρακτικό επίπεδο, τα δεδομένα των σχετικών μελετών υποδηλώνουν ότι η χημειοθεραπεία ή οι άλλες αντι-νεοπλασματικές θεραπείες δεν αυξάνουν σημαντικά τον κίνδυνο θνησιμότητας από...

FDA: Η ακτινοβολία των smartphones δεν προκαλεί καρκίνο

Σε μια νέα έκθεσή της, η Υπηρεσία Τροφίμων και Φαρμάκων (FDA) των ΗΠΑ αναφέρει ότι επανεξέτασε τις σχετικές επιστημονικές έρευνες που δημοσιεύθηκαν τα τελευταία...

Νέα ανακάλυψη, νέα ελπίδα για τον καρκίνο

Ένα νεοανακαλυφθέν τμήμα του ανοσοποιητικού μας συστήματος θα μπορούσε να αξιοποιηθεί για την αντιμετώπιση όλων των ειδών καρκίνου, σύμφωνα με επιστήμονες του πανεπιστημίου Cardiff...
- Advertisment -

Ροή Ειδήσεων

2021 ASCO Annual Meeting Research Round Up: Advances in Treating Lung Cancer, Breast Cancer, and Sarcoma

In the annual Research Round Up series, Cancer.Net Associate Editors answer the question, “What was the most exciting or practice-changing research in your field...

Avapritinib Not Superior to Regorafenib in Terms of Median PFS in Third-Line or Later Treatment of Patients with Unresectable or Metastatic GIST

Findings from an open-label, randomised, multicentre phase III VOYAGER study indicate that avapritinib is not superior to regorafenib in terms of median progression-free survival...

Patients less likely to rate cancer care as ‘very good’ during pandemic

Almost a third of cancer patients have reported receiving worse care since COVID-19 began, according to a new survey commissioned by Cancer Research UK. Whilst...

How to Avoid Spreading Harmful Chemo Chemicals to Members of Your Household

Cancer is not contagious, and neither is chemotherapy. However, harmful chemotherapy drugs can sometimes still be present in the bodily fluids of a person...

The right combination for early detection

The upcoming Early Detection of Cancer Conference brings together experts from multiple disciplines to share ground breaking research and progress in the field. Here...

Can’t Sleep? Tips for Coping with Insomnia

Insomnia* is common for cancer patients**, as well as for the general population. We frequently hear from our patients and their caregivers that sleeping through the night...